SCHEMBL7658570

SCHEMBL7658570

O=S(=O)(Cl)c1ccc(Oc2ccc(-c3cccnc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.59
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA9 Q16790 1/20 0.59
CYP3A4 P08684 2/20 0.48
CYP19A1 P11511 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CYP2A6 P11509 3/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
PTGS2 P35354 2/20 0.47
CYP11B2 P19099 4/20 0.45
CYP11B1 P15538 3/20 0.45
MKNK1 Q9BUB5 3/20 0.45
MKNK2 Q9HBH9 3/20 0.45
CYP17A1 P05093 1/20 0.44
PSMB5 P28074 1/20 0.44
KIF11 P52732 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2329929 0.90 CA2 (0.71) CA2CA12CA1CA9CYP3A4
SCHEMBL2845658 0.85 LMNA (0.55) CA2CA12CA1CA9CYP19A1
Hydrochloric Acid SCHEMBL7658573 0.85 CA2 (0.56) CA2CA12CA1CA9CYP3A4
SCHEMBL9539212 0.83 ALDH1A1 (0.56) CA2CA12CA1CA9ALDH1A1
SCHEMBL7649531 0.82 CYP3A4 (0.43) CA2CA12CA1CA9CYP3A4
SCHEMBL7657519 0.82 HTT (0.44) CA2CA1CYP3A4CYP2D6ALDH1A1
SCHEMBL7013344 0.80 CYP11B2 (0.60) CYP3A4CYP19A1CYP2D6CYP2C9CYP2C19
SCHEMBL7892614 0.80 SOS1 (0.58) CA2CA1CA9ALDH1A1PTGS2
SCHEMBL18194403 0.78 CA2 (0.73) CA2CA12CA1CA9CYP3A4
SCHEMBL433497 0.77 HTT (0.58) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed